Researcher in lab

Find clinical trials

Our clinical trial portfolio is one of the largest in the country. We have more than 700 clinical trials open across 30 clinical units.

Find Melbourne Sexual Health Centre research studies and clinical trials
Clear filter
636 clinical trials found
Clinical trials

SMITE

SMITE: Superiority of Migraine Inpatient Treatment with Eptinezumab (ACTRN12621001616864)

No longer recruiting

SNAP

Staphylococcus aureus Network Adaptive Platform trial (SNAP) (NCT05137119)

Currently recruiting

SNaPP Study

Sugammadex, neostigmine and postoperative pulmonary complications (the SNaPP Study) (ACTRN12623000394640)

No longer recruiting

SNDX-5613-0700

A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of SNDX-5613 in Patients with Relapsed/Refractory Leukemias, Including Those Harboring an MLL/KMT2A Gene Rearrangement or Nucleophosmin 1 (NPM1) Mutation (NCT04065399)

Currently recruiting

SNDX-5613-0708

Phase 1, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate Safety, Tolerability, and Clinical Activity of SNDX-5613 in Combination with Intensive Chemotherapy in Participants with Newly Diagnosed Acute Myeloid Leukemias Harboring Alterations in Lysine-specific Methyltransferase 2A [KMT2A/MLL], Nucleophosmin 1 [NPM1], and Nucleoporin 98 [NUP98] Genes (NCT06226571)

Currently recruiting

SNIPER

Stereotactic ablative body radiation therapy with Nodal Irradiation for ProstatE canceR (ACTRN12625000259448)

Currently recruiting

SNV1521

A PHASE 1, OPEN-LABEL DOSE ESCALATION AND EXPANSION STUDY OF SNV1521 IN PARTICIPANTS WITH ADVANCED SOLID TUMORS (NCT06220864)

Currently recruiting

SOCRATES

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (ACTRN12621001444875p)

Currently recruiting

SODa-BIC

SODa-BIC: Sodium Bicarbonate For Metabolic Acidosis in the Intensive Care Unit, A Multicentre, Randomised, Double-Blind Clinical Trial (NCT05697770)

Currently recruiting

SPG302-SCZ-201

A Randomized, Placebo-controlled, Double-blind Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacodynamics of SPG302 in adult participants diagnosed with Schizophrenia (NCT06442462)

Currently recruiting

SPK-8011-8016-LTFU

A Multi-Center Evaluation of the Long-Term Safety and Efficacy of Spark-sponsored Gene Therapies in Males with Hemophilia A (NCT03432520)

Currently recruiting

SPYRAL AFFIRM

The SPYRAL AFFIRM Global Clinical Study of Renal Denervation with the Symplicity Spyral Renal Denervation System in Subjects with Uncontrolled Hypertension (SPYRAL AFFIRM) (NCT05198674)

Currently recruiting

STALL HFpEF 2

Randomized trial of medical therapy versus conduction system pacing with AV node ablation in persistent atrial fibrillation [AF] and heart failure with preserved ejection fraction (ACTRN12625000466448)

Currently recruiting

STAR AF

STRATEGIES FOR CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION: A RANDOMIZED, COMPARATIVE STUDY (STAR AF 3) (NCT04428944)

Currently recruiting

STARWARS

Salvage sTereotactic Ablative radiotherapy for Recurrent prostate cancer With Androgen suppression and Rectal Spacer (ACTRN12625000224426)

Currently recruiting

STOP

The Silicosis Treatment Of Prednisolone (STOP) Study: A pilot study assessing the effectiveness of Prednisolone on respiratory function in adults with silicosis. (ACTRN12623000622606)

Currently recruiting

STOP-GAP

A Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP) (NCT02821013)

Currently recruiting

STOP-MS

Phase III, multicentre, randomised, double-blinded, placebo-controlled, MAMS trial of SpironolacTone and famciclOvir in the treatment of Progressive MS to prevent disability progression (STOP-MS) (ACTN12621001502820)

We have selected two potential anti-Epstein-Barr virus therapies (spironolactone and famciclovir) to test in an innovative multi-stage, multi-arm trial in order to identify the best treatment for progressive MS. Treatments will be compared to dummy-treatment.
Currently recruiting

STOP-MSU

A phase II randomised, placebo-controlled, investigator-driven trial of tranexamic acid within 2 hours of intracerebral haemorrhage (NCT03385928)

Currently recruiting

STOPit

Study of tofacitinib for the treatment of chronic pouchitis (STOPit) (ACTRN12621000173897)

Currently recruiting
26 27 28 29 30